![]() |
市場調查報告書
商品編碼
2058924
個人化營養食品市場預測至2034年:按產品類型、技術、應用、分銷管道和最終用戶分類的全球分析Personalized Nutrition Food Market Forecasts to 2034 - Global Analysis By Product Type, Technology, Application, Distribution Channel, and End User |
||||||
根據 Stratistics MRC 的數據,預計到 2034 年,全球個人化營養食品市場規模將達到 610.2 億美元,在預測期內複合年成長率為 14.6%,從 2026 年的 1.5 億美元成長到 2034 年的 610.2 億美元。
個人化營養食品是指根據個人的飲食需求、健康狀況、遺傳因素和生活方式偏好量身訂製的食品。這些食品的研發運用了健康體檢數據、人工智慧演算法和營養分析。其目標是透過解決特定的營養不足和目標(例如體重管理、健身和疾病預防)來最佳化健康。消費者對客製化健康解決方案日益成長的需求正在推動市場成長。營養科學和數位健康技術的進步正在推動食品產業的大規模個人化發展。
對客製化餐點的需求日益成長
隨著人們對營養與長期健康之間關聯的認知不斷提高,消費者越來越傾向於選擇個人化的飲食方案,而非千篇一律的計畫。健康追蹤設備和應用程式等技術的進步進一步推動了這一需求,使人們能夠更準確地監測營養攝取。此外,肥胖和糖尿病等文明病的日益普遍,也促使消費者更加關注如何根據自身獨特的代謝需求來選擇合適的飲食。這種趨勢在重視個人化和便利性的年輕一代中尤其明顯。
消費者膳食數據準確性的局限性
個人化飲食方案嚴重依賴使用者自我報告的數據。不準確的數據會降低建議的有效性。缺乏標準化的資料收集方式限制了其可靠性。隱私問題限制了敏感健康資訊的共用。追蹤應用程式的錯誤進一步加劇了這些挑戰。這些因素正在減緩市場擴張。
基於DNA的個人化飲食發展
基因檢測能夠達到精準的個人化飲食。基於DNA的解決方案正變得越來越經濟實惠且易於取得。企業正與基因組分析公司合作進行創新。消費者更信任以科學為依據的營養訊息,而非千篇一律的營養方案。人們對營養吸收差異的認知不斷提高,正在推動市場需求。預計該領域將快速發展。
個人化營養監管方面的不確定性
個人化營養領域的健康聲明正受到嚴格審查。監管機構要求對相關建議進行科學檢驗。缺乏全球標準導致合規性問題。企業若發布檢驗的聲明,將面臨損害自身聲譽的風險。法律糾紛也可能阻礙創新。監管政策的清晰明確對於市場穩定至關重要。
新冠疫情顯著加速了個人化營養食品的普及,消費者健康意識增強,積極主動地提升免疫力和健康水準。封鎖措施和醫療服務中斷促使人們尋求預防性解決方案,包括有助於增強整體健康和抵抗力的客製化飲食。消費者對遠端諮詢和個人化飲食計劃的日益依賴,導致對數位健康平台和線上營養服務的需求激增。同時,供應鏈中斷也為產品供應帶來了挑戰,這一趨勢在受疫情嚴重影響的地區尤其突出。
在預測期內,整體健康產業預計將佔據最大的市場佔有率。
在預測期內,綜合健康領域預計將佔據最大的市場佔有率。這主要歸功於消費者日益重視個人化營養,以進行預防性醫療保健和改善生活方式。注重健身的人群正在推動對能夠提升能量和運動表現的客製化飲食的需求。健康應用程式和數位平台的普及也促進了該領域的成長。千禧世代和Z世代是主要使用者群體,他們重視便利性和個人化。人們對自我護理和免疫力的意識不斷提高,進一步強化了這項需求。隨著預防性醫療保健趨勢的發展,預計該領域將繼續保持主導地位。
預計在預測期內,有醫療需求的患者群體將呈現最高的複合年成長率。
在預測期內,受糖尿病、心血管疾病和胃腸道疾病等慢性病盛行率上升的推動,有醫療需求的患者群體預計將呈現最高的成長率。個人化營養解決方案正日益普及,成為醫療治療的補充手段。醫療服務提供者建議採用有針對性的飲食干預措施來改善患者的治療效果。對治療性飲食的需求不斷成長,也推動了這一領域的擴張。患者正在尋求針對自身特定疾病量身定做的解決方案。
在預測期內,北美預計將佔據最大的市場佔有率,這主要得益於其先進的醫療保健基礎設施和較高的消費者健康意識。數位健康技術的積極應用正在推動個人化營養的發展。領先企業和研究機構的存在正在推動創新。預防醫學的趨勢在該地區已相當成熟。消費者願意為長期的健康益處而投資於客製化的飲食方案。
在預測期內,亞太地區預計將呈現最高的複合年成長率,這主要得益於可支配收入的成長和健康意識的提高。中國、印度和日本等國家正迅速接受個人化營養解決方案。數位化和行動醫療平台正在推動市場滲透。文明病的日益普遍也刺激了對個人化飲食的需求。預防性醫療保健的意識正在都市區中不斷增強。亞太地區將成為全球成長最快的地區。
According to Stratistics MRC, the Global Personalized Nutrition Food Market is accounted for $20.15 billion in 2026 and is expected to reach $61.02 billion by 2034 growing at a CAGR of 14.6% during the forecast period. Personalized Nutrition Food refers to food products tailored to individual dietary needs, health conditions, genetics, and lifestyle preferences. These foods are developed using data from health assessments, AI algorithms, and nutritional profiling. They aim to optimize health outcomes by addressing specific deficiencies or goals such as weight management, fitness, or disease prevention. Increasing consumer demand for customized health solutions is driving growth. Advances in nutrition science and digital health technologies are enabling scalable personalization in the food industry.
Growing demand for tailored diets
Rising awareness about the link between nutrition and long-term health outcomes has encouraged consumers to seek customized dietary solutions rather than generic plans. This demand is further supported by technological advancements in health tracking devices and apps, which allow individuals to monitor their nutritional intake more precisely. Additionally, the growing prevalence of lifestyle-related diseases such as obesity and diabetes has made consumers more conscious of adopting diets that suit their unique metabolic needs. The trend is particularly strong among younger demographics who value personalization and convenience in their food choices.
Limited consumer dietary data accuracy
Personalized diets rely heavily on self-reported data. Inaccuracies reduce effectiveness of recommendations. Lack of standardized data collection limits reliability. Privacy concerns restrict sharing of sensitive health details. Errors in tracking apps add to the challenge. These factors slow market scalability.
DNA-based diet customization growth
Genetic testing enables precise diet personalization. DNA-based solutions are becoming affordable and accessible. Companies are partnering with genomics firms for innovation. Consumers trust science-backed nutrition more than generic plans. Rising awareness of nutrient absorption differences drives demand. This segment is expected to expand rapidly.
Regulatory uncertainty in personalized claims
Health claims in personalized nutrition face strict scrutiny. Regulators demand scientific validation of recommendations. Lack of global standards creates compliance issues. Companies risk reputational damage from unverified claims. Legal disputes may slow innovation. Regulatory clarity is essential for market stability.
The Covid-19 pandemic significantly accelerated the adoption of personalized nutrition foods as consumers became more health-conscious and proactive about immunity and wellness. Lockdowns and disruptions in healthcare access prompted individuals to seek preventive solutions, including tailored diets that could support overall health and resilience. Digital health platforms and online nutrition services witnessed a surge in demand, as consumers increasingly relied on remote consultations and personalized diet plans. At the same time, supply chain disruptions posed challenges for product availability, particularly in regions heavily affected by the pandemic.
The general wellness segment is expected to be the largest during the forecast period
The general wellness segment is expected to account for the largest market share during the forecast period as consumers increasingly adopt personalized nutrition for preventive health and lifestyle improvement. Fitness-conscious individuals are driving demand for customized diets that enhance energy and performance. The popularity of wellness apps and digital platforms supports growth in this segment. Millennials and Gen Z are the primary adopters, valuing convenience and personalization. Rising awareness of self-care and immunity further strengthens demand. Preventive healthcare trends ensure this segment remains dominant.
The patients with medical needs segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the patients with medical needs segment is predicted to witness the highest growth rate due to the rising prevalence of chronic diseases such as diabetes, cardiovascular disorders, and gastrointestinal issues. Personalized nutrition solutions are increasingly being used to complement medical treatments. Healthcare providers are recommending targeted dietary interventions to improve patient outcomes. Growing demand for therapeutic diets supports expansion in this segment. Patients are seeking customized solutions that address specific medical conditions.
During the forecast period, the North America region is expected to hold the largest market share owing to its advanced healthcare infrastructure and high consumer awareness. Strong adoption of digital health technologies supports personalized nutrition growth. The presence of leading companies and research institutions drives innovation. Preventive healthcare trends are well established in this region. Consumers are willing to invest in customized diets for long-term health benefits.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR driven by rising disposable incomes and increasing health consciousness. Countries such as China, India, and Japan are witnessing rapid adoption of personalized nutrition solutions. Digitalization and mobile health platforms support market penetration. The growing prevalence of lifestyle-related diseases fuels demand for tailored diets. Preventive healthcare awareness is expanding across urban populations. Asia Pacific will be the fastest-growing region globally.
Key players in the market
Some of the key players in Personalized Nutrition Food Market include Nestle S.A., PepsiCo, Inc., Danone S.A., Herbalife Nutrition Ltd., Amway Corporation, General Mills, Inc., Glanbia plc, Nutrigenomix Inc., Viome Life Sciences, ZOE Ltd., DNAfit, Persona Nutrition, Abbott Laboratories, Bayer AG and GNC Holdings.
In April 2026, Abbott Laboratories reported significant momentum following the successful launch and clinical trial results of the FreeStyle Libre 3 system for Type 2 diabetes management. This product-led initiative demonstrates superior glucose outcomes compared to traditional fingersticks, allowing the system to autonomously communicate with digitally connected devices for real-time, acute therapy adjustments.
In March 2026, Herbalife Ltd. announced a definitive agreement to acquire certain assets from Bioniq, a UK-based personalized supplements company, for an initial $10 million with up to $95 million in contingent payments. This strategic collaboration combines Bioniq's patented biomarker-driven personalization engine with Herbalife's global distributor network to deliver data-driven wellness solutions to consumers in Europe and the United States later this year.
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) are also represented in the same manner as above.